AstraZeneca's failed late-stage trial for Wainua was never expected to have a major financial impact on the company.Most analysts estimate the trial miss wiped...
CNBC's Jim Cramer said Monday that investors shouldn't fear the latest market rotation. Instead, he thinks it's creating buying opportunities in several high-quality stocks...
An airport lounge — without the security screening or boarding pass. Credit card companies American Express and Chase are increasingly waging their luxury lounge...
Moderna's expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty following the Covid-19 pandemic,...
